Short-term insulin therapy at the time of diagnosis of Type 2 diabetes leads to better glycemic control and improved beta cell function

Short-term insulin therapy at the time of diagnosis of Type 2 diabetes leads to better glycemic control and improved beta cell function

Background: Impaired insulin secretion and insulin resistance are the underlying pathophysiological defects in Type 2 diabetes (T2DM) that lead to hyperglycaemia. The β-cell defect in T2DM is usually progressive, leading to eventual β-cell exhaustion and dependence on insulin. It is known that gluco...

Full description

Bibliographic Details
Main Authors: Siddharth Madnani, Ranjit Mohan Anjana, Sanjay Baliram Warade, Muthukrishnan Varalakshmi, Brijendra Kumar Srivastava, Prasanna Kumar Gupta, Philips Routray, Chandru Sundaramoorthy, Ranjit Unnikrishnan, Viswanathan Mohan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Diabetology
Subjects:
Impaired insulin secretion
insulin resistance
insulin therapy
Type 2 diabetes
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2019;volume=10;issue=3;spage=97;epage=101;aulast=Madnani

Internet

http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2019;volume=10;issue=3;spage=97;epage=101;aulast=Madnani

Similar Items